middle.news
Immutep Accelerates Global Lung Cancer Trial with 38% Patient Enrolment
8:42am on Tuesday 16th of December, 2025 AEDT
•
Biotechnology
Read Story
Immutep Accelerates Global Lung Cancer Trial with 38% Patient Enrolment
8:42am on Tuesday 16th of December, 2025 AEDT
Key Points
289 patients enrolled globally, 38% of target
Over 120 clinical sites activated in 27 countries
First US clinical sites approved post-FDA Project Optimus
Futility analysis scheduled for Q1 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IMM
OPEN ARTICLE